Stay updated on Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial

Sign up to get notified when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-13T20:45:43.000Z thumbnail image
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the comparison of Ertugliflozin versus Hydrochlorothiazide in reducing sympathetic neural overactivity in patients with hypertension and recently-diagnosed type 2 diabetes.
    Difference
    0.1%
    Check dated 2024-06-06T14:20:53.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying the diagnosis, age range, health conditions, and prior treatments required for inclusion in the study.
    Difference
    16%
    Check dated 2024-05-22T19:48:22.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:14:20.000Z thumbnail image

Stay in the know with updates to Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.